Holen Sie sich die Stockscreener-App
178.84
1.64%
2.89
Handel nachbörslich:
178.84
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$175.95
Offen:
$175.78
24-Stunden-Volumen:
1.11M
Relative Volume:
1.23
Marktkapitalisierung:
$20.00B
Einnahmen:
$10.52B
Nettoeinkommen (Verlust:
$999.00M
KGV:
21.39
EPS:
8.3628
Netto-Cashflow:
$1.22B
1W Leistung:
-0.79%
1M Leistung:
-0.27%
6M Leistung:
+0.50%
1J Leistung:
+15.17%
1-Tages-Spanne:
$174.36
$179.15
1-Wochen-Bereich:
$174.33
$180.63
52-Wochen-Spanne:
$148.70
$197.55
Quest Diagnostics Inc Stock (DGX) Company Profile
Firmenname
Quest Diagnostics Inc
Sektor
Branche
Telefon
(973) 520-2700
Adresse
500 PLAZA DRIVE, SECAUCUS
Vergleichen Sie DGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
178.84 | 19.57B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
564.88 | 213.17B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
214.06 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.94 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.69 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
213.88 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-01-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | Fortgesetzt | Evercore ISI | In-line |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-06-29 | Eingeleitet | Piper Sandler | Neutral |
| 2023-05-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-01-23 | Eingeleitet | Evercore ISI | In-line |
| 2022-11-17 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-23 | Herabstufung | UBS | Buy → Neutral |
| 2022-02-02 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Hochstufung | UBS | Neutral → Buy |
| 2021-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Hochstufung | Argus | Hold → Buy |
| 2020-07-29 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-06-09 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Herabstufung | Goldman | Neutral → Sell |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-03-18 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-01-31 | Herabstufung | Argus | Buy → Hold |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Herabstufung | Goldman | Buy → Neutral |
Alle ansehen
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
Quest Diagnostics (NYSE: DGX) to webcast Citi 2025 conference at 3:15 p.m. ET Dec. 2 - Stock Titan
Is Quest Diagnostics Incorporated (QDI) stock positioned for secular growthJuly 2025 Update & AI Driven Stock Reports - newser.com
Will Quest Diagnostics Incorporated stock gain from lower inflationTrade Entry Summary & Verified Short-Term Trading Plans - newser.com
Forecasting Quest Diagnostics Incorporated price range with options dataOptions Play & Low Volatility Stock Recommendations - newser.com
Can Quest Diagnostics Incorporated stock beat analyst consensusJuly 2025 Institutional & Safe Capital Investment Plans - newser.com
Nicholas Company Inc. Sells 22,730 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Cambiar Investors LLC Decreases Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
How supply chain issues affect Quest Diagnostics Incorporated stockEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Quest Diagnostics Incorporated stock trend forecast2025 Price Action Summary & Expert Curated Trade Ideas - newser.com
Published on: 2025-11-03 04:13:22 - newser.com
Quest Diagnostics (DGX): Assessing Valuation After Recent Steady Share Price Performance - Yahoo Finance
Is Quest Diagnostics Incorporated stock cheap compared to fundamentals2025 Risk Factors & AI Enhanced Trade Execution Alerts - newser.com
Why Analysts See the Story Changing for Quest Diagnostics Following New Tests and Upgraded Forecasts - Yahoo Finance
Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance
Bessemer Group Inc. Has $519,000 Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Integrity Alliance LLC. Reduces Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Bought by Keybank National Association OH - MarketBeat
Why Quest Diagnostics Incorporated stock is favored by top institutionsOil Prices & Growth Focused Stock Reports - newser.com
Quest Diagnostics Incorporated stock outlook for YEAR2025 Stock Rankings & AI Enhanced Execution Alerts - newser.com
How Quest Diagnostics Incorporated stock performs in high volatility marketsBear Alert & Expert Curated Trade Setups - newser.com
What Fibonacci levels say about Quest Diagnostics Incorporated reboundJuly 2025 Breakouts & Safe Capital Growth Tips - newser.com
Is Quest Diagnostics Incorporated stock in correction or buying zoneDay Trade & Breakout Confirmation Trade Signals - newser.com
Quest Diagnostics Incorporated $DGX Stock Holdings Increased by Envestnet Asset Management Inc. - MarketBeat
What technical signals suggest for Quest Diagnostics Incorporated stockWeekly Loss Report & Technical Analysis for Trade Confirmation - newser.com
How Quest Diagnostics Incorporated (QDI) stock reacts to stronger dollarJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com
Exit strategy if you’re trapped in Quest Diagnostics IncorporatedJuly 2025 Pullbacks & High Conviction Buy Zone Alerts - newser.com
Can Quest Diagnostics Incorporated stock surprise with earnings upsideEarnings Summary Report & AI Driven Stock Movement Reports - newser.com
Will Quest Diagnostics Incorporated stock return to pre crisis levelsMarket Risk Analysis & Low Volatility Stock Suggestions - newser.com
Fjarde AP Fonden Fourth Swedish National Pension Fund Buys 11,000 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Ashton Thomas Private Wealth LLC Acquires 2,285 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
How currency fluctuations impact Quest Diagnostics Incorporated stockEntry Point & AI Driven Stock Reports - newser.com
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
J.P. Morgan Sticks to Their Hold Rating for Quest Diagnostics (DGX) - The Globe and Mail
Can Quest Diagnostics Incorporated (QDI) stock retain market dominanceTrade Risk Assessment & Expert Approved Momentum Trade Ideas - newser.com
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Sumitomo Mitsui Trust Group Inc. Decreases Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Finanzdaten der Quest Diagnostics Inc-Aktie (DGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.15%
1.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):